Typing of Candida isolates from patients with invasive infection and concomitant colonization

Scandinavian Journal of Infectious Diseases

Volumn 42, Issue 2, 2010, Pages 109-113

  Brillowska Dabrowska, Anna ^a,b   Bergmann, Olav ^c   Jensen, Irene Moeller ^c   Jarløv, Jens Otto ^c   Arendrup, Maiken C ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b GDANSK UNIVERSITY OF TECHNOLOGY   (Poland)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANDIDA; CANDIDEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FUNGAL COLONIZATION; FUNGUS CULTURE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HUMAN; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PREDICTION; RANDOM AMPLIFIED POLYMORPHIC DNA;

CANDIDA; CANDIDIASIS; CARRIER STATE; DNA FINGERPRINTING; DNA, FUNGAL; FUNGEMIA; HUMANS; MYCOLOGICAL TYPING TECHNIQUES; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; SEQUENCE ANALYSIS, DNA;

EID: 75749120574     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365540903348336     Document Type: Article

References (25)

1. Garey KW, Rege M, Pai MP. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 2006;43:25-31
2. Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005; 49:3640-3645
3. Arendrup MA, Fuursted K, Gahrn-Hansen B, Jensen IM, Knudsen JD, Lundgren B, et al. Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility. J Clin Microbiol 2005;43:4434-4440
4. Laupland KP, Gregson DB, Church DL, Ross T, Elsayed S. Invasive Candida species infections: a 5 year populationbased assessment. J Antimicrob Chemother 2005;56:532-537
5. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994;220:751-758
6. Lecciones JA, Lee JW, Navarro EE, Witebsky FG, Marshall D, Steinberg SM, et al. Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin Infect Dis 1995;14:524
7. Favero A. Management of fungal infections in neutropenic patients: more doubts than certainties? Int J Antimicrob Agents 2000;16:135-137
8. Karabinis A, Hill C, Leclerq B, Tancrede C, Baume D, Andremont A. Risk factors for candidemia in cancer patients: a case-control study. J Clin Microbiol 1988;26:429-432
9. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital-acquired candidemia. Arch Intern Med 1989;149:2349-2353
10. Dalle F, Franco N, Lopez J, Vagner O, Caillot D, Chavanet P, et al. Comparative genotyping of Candida albicans bloodstream and nonbloodstream isolates at a polymorphic microsatellite locus. J Clin Microbiol 2000;38:554-559
11. Metzgar D, van Belkum A, Field D, Haubrich R, Wills C. Random amplifi cation of polymorphic DNA and microsat ellite genotyping of pre-and posttreatment isolates of Candida spp. from human immunodefi ciency virus-infected patients on different fluconazole regimens. J Clin Microbiol 1998;36:2308-2313
12. Lass-Flörl C, Gunsilius E, Gastl G, English M, Koch G, Ulmer H, et al. Fungal colonization in neutropenic patients: a randomized study comparing itraconazole solution and amphotericin B solution. Ann Hematol 2003;82:565-569
13. Lunel FV, Licciardello L, Stefani S, Verbrugh HA, Melchers WJ, Meis JF, et al. Lack of consistent short sequence repeat polymorphisms in genetically homologous colonizing and invasive Candida albicans strains. J Bacteriol 1998;15:3771-3778
14. Reagan DR, Pfaller MA, Hollis RJ, Wenzell RP. Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and DNA probe. J Clin Microbiol 1990;12:2733-2738
15. Bougnoux ME, Tavanti A, Bouchier C, Gow NA, Magnier A, Davison AD, et al. Collaborative consensus for optimized multilocus sequence typing of Candida albicans. J Clin Microbiol 2003;41:5265-5266 (Pubitemid 37429956)
16. Arendrup MC, Bergmann OJ, Larsson L, Nielsen HV, Jarløv JO, Christensson B. Detection of candidaemia in patients with and without underlying haematological disease. Clin Microbiol Infect. In press
17. Lian C, Zhao J, Zhang Z, Liu W. Genotype of Candida species associated with different conditions of vulvovaginal candidosis. Mycoses 2004;47:495-502
18. Pinto PM, Resende MA, Koga-Ito C, Tendler M. Genetic variability analysis among clinical Candida spp. isolates using random amplified polymorphic DNA. Rev Soc Bras Med Trop 2004;99:147-152
19. Jacobsen MD, Gow NA, Maiden MC, Shaw DJ, Odd FC. Strain typing and determination of population structure of Candida krusei by multilocus sequence typing. J Clin Microbiol 2007;2:317-323
20. Lockhart SR, Joly S, Pujol C, Sobel JD, Pfaller MA, Solet DR. Development and verifi cation of fingerprinting probes for Candida glabrata. Microbiology 1997;143:3733-3746
21. Dodgson AR, Pujol C, Denning DW, Soll DR, Fox AJ. Multilocus sequence typing of Candida glabrata reveals geographically enriched clades. J Clin Microbiol 2003;41:5709-5717
22. Bautista-Munoz C, Boldo XM, Villa-Tanaca L, Hernandez-Rodríguez C. Identification of Candida spp. by randomly amplified polymorphic DNA analysis and differentiation between Candida albicans and Candida dubliniensis by direct PCR methods. J Clin Microbiol 2003;41:414-420
23. Lehman PF, Lin D, Lasker BA. Genotypic Identification and characterization of species and strains within the genus Candida by using random amplified polymorphic DNA. J Clin Microbiol 1992;30:3249-3254
24. Borst A, Raimer MT, Warnock DW, Morrison CJ, Arthington-Skaggs BA. Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole. Antimicrob Agents Chemother 2005;49:783-787
25. Hattori H, Iwata T, Nakagawa Y, Kawamoto F, Tomita Y, Kikuchi A, et al. Genotype analysis of Candida albicans isolates obtained from different body locations of patients with superfi cial candidiasis using PCRs targeting 25S rDNA and ALT repeat sequences of the RPS. J Dermatol Sci 2006;42:31-46